Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionAugustine Asset Management Inc
Latest Disclosed Ownership1,270 shares
Latest Disclosed Value $ 1,168,108
Augustine Asset Management Inc reports 0.32% increase in ownership of LLY / Eli Lilly and Company

On April 13, 2026 - Augustine Asset Management Inc filed a 13F-HR form disclosing ownership of 1,270 shares of Eli Lilly and Company (US:LLY) valued at $1,168,108 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 1,266 shares of Eli Lilly and Company. This represents a change in shares of 0.32% during the quarter. The current value of the position is $1,370,051 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F Eli Lilly & Co COM 532457108 1,270 4 0.32 1,168 -14.12 0.2630
2026-01-16 2025-12-31 13F Eli Lilly & Co COM 532457108 1,266 -7 -0.55 1,361 40.06 0.2716
2025-10-22 2025-09-30 13F Eli Lilly & Co COM 532457108 1,273 33 2.66 971 0.52 0.1954
2025-07-16 2025-06-30 13F Eli Lilly & Co COM 532457108 1,240 93 8.11 967 2.01 0.2586
2025-04-25 2025-03-31 13F Eli Lilly & Co COM 532457108 1,147 -481 -29.55 947 -24.60 0.2768
2025-01-29 2024-12-31 13F Eli Lilly & Co COM 532457108 1,628 1,221 300.00 1,257 248.89 0.3303
2024-10-25 2024-09-30 13F Eli Lilly & Co COM 532457108 407 3 0.74 361 -1.37 0.1259
2024-08-01 2024-06-30 13F Eli Lilly & Co COM 532457108 404 -9 -2.18 366 13.71 0.1413
2024-04-26 2024-03-31 13F Eli Lilly & Co COM 532457108 413 -6 -1.43 321 31.56 0.1340
2024-01-24 2023-12-31 13F Eli Lilly & Co COM 532457108 419 -40 -8.71 244 -0.81 0.1081
2023-11-14 2023-09-30 13F Eli Lilly & Co COM 532457108 459 459 247 0.1139
2022-10-24 2022-09-30 13F Eli Lilly & Co COM 532457108 0 -1,423 -100.00 0 -100.00
2022-08-02 2022-06-30 13F Eli Lilly & Co COM 532457108 1,423 12 0.85 461 14.11 0.2831
2022-04-27 2022-03-31 13F Eli Lilly & Co COM 532457108 1,411 90 6.81 404 10.68 0.2029
2022-02-01 2021-12-31 13F Eli Lilly & Co COM 532457108 1,321 0 0.00 365 19.67 0.1788
2021-10-26 2021-09-30 13F Eli Lilly & Co COM 532457108 1,321 69 5.51 305 6.27 0.1625
2021-07-20 2021-06-30 13F Eli Lilly & Co COM 532457108 1,252 7 0.56 287 23.18 0.1481
2021-05-05 2021-03-31 13F Eli Lilly & Co COM 532457108 1,245 9 0.73 233 11.48 0.1228
2021-01-26 2020-12-31 13F Eli Lilly & Co COM 532457108 1,236 1,236 209 0.1083
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.